Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- Check4 days agoChange DetectedThe Record History page now includes Revision: v3.3.4 and removes Revision: v3.3.3.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Record History now includes a new entry documenting the addition of Study Status with revision v3.3.3 dated 2025-12-18, and the HHS Vulnerability Disclosure link was removed (revision v3.3.2) on 2025-09-22.SummaryDifference0.3%

- Check55 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2, indicating a small product/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe site-wide notice about lapse in government funding and operating status that was shown on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedNo core study content or scheduling data changed; the observed differences appear to be UI/layout updates on the Record History page, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check105 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0; removed the prior v3.1.0 reference.SummaryDifference9%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.